Is there a Role for Epigenetic Enhancement of Immunomodulatory Approaches to Cancer Treatment?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|18|1|5-15

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.18, Iss.1, 2017-12, pp. : 5-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outlook on Epigenetic Therapeutic Approaches for Treatment of Gastric Cancer

By  

Current Cancer Drug Targets, Vol. 18, Iss. 1, 2017-12 ,pp. : 65-88

Bentham Science Publishers

Access to resources Recommend Favorite

An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors

By  

Current Cancer Drug Targets, Vol. 12, Iss. 4, 2012-04 ,pp. : 439-452

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Regulation and Therapeutic Approaches in Cancer

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 15, 2008-10 ,pp. : 1367-1378

Bentham Science Publishers

Access to resources Recommend Favorite

Thalidomide and immunomodulatory drugs in the treatment of cancer

By Bamias Aristotle   Dimopoulos Meletios A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 1, 2005-01 ,pp. : 45-55

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy Approaches in Cancer Treatment

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 9, 2015-01 ,pp. : 771-781

Bentham Science Publishers

Access to resources Recommend Favorite